President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs he has already imposed on most goods entering the United States ...

The Nigeria Customs Service has announced a two-year exemption from import duty and Value Added Tax for critical raw materials essential for the production of pharmaceuticals. The exemption ...

Trump said he wants to bring more drug manufacturing to the U.S. At a political fundraising dinner on Tuesday night, President Donald Trump said he plans to announce tariffs on pharmaceuticals soon.

The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports. By Alex Travelli Reporting from New Delhi An important segment of India ...

But one sector - pharmaceuticals - is still waiting to learn what taxes it faces, with the US president expected to place tariffs on the industry in the coming days, vowing on 8 April that they ...

The Trump administration is kicking off investigations into imports of pharmaceuticals and semiconductors as part of a bid to impose tariffs on both sectors on national security grounds ...

Rhythm Pharmaceuticals, Inc. (RYTM) shares ended the last trading session 17.1% higher at $54.96. The jump came on an impressive volume with a higher-than-average number of shares changing hands ...

Recursion Pharmaceuticals' stock jumped after the FDA announced plans to replace the use of animals in drug testing. Recursion is a leader in AI-powered drug discovery and development. It remains ...

Continuing his economic onslaught, US President Donald Trump said on Tuesday that Washington is planning to announce a "major" tariff on pharmaceutical imports soon. India's pharmaceuticals sector ...

European pharmaceutical companies have warned EU chiefs that Donald Trump's tariffs could cause an 'exodus' from Europe and toward the United States. The European Commission president was warned ...

- 99.8% tumor growth inhibition achieved with a single dose of ATNM-400 in preclinical prostate cancer models - ATNM-400 accumulated in tumors for up to 144 hours and showed minimal uptake in ...

The head of one of America's largest pharmaceutical companies says he does not support tariffs on Australian pharmaceuticals as US President Donald Trump considers more trade restrictions.